Answers are grounded in this paper and cite their sources.
e a n a s s o c i a t i o n b e t w e e n N -acetyltransferase 2 (NAT2 )-haplotypes/diplotypes and adverse effects in Japanese pulmonary tuberculosis patients. METHODS:We studied 100 patients with pulmonary TB treated with anti-TB drugs including INH.The frequencies and distributions of single nucleotide polymorphisms, haplotypes, and diplotypes of NAT2 were determined by the PCR-restriction fragment length polymorphism method, and the results were compared between TB patients with and without adverse effect, using multivariate logistic regression analysis. RESULTS:Statistical analysis revealed that the frequency of a variant haplotype, NAT2*6A , was significantly increased in TB patients with hepatotoxicity, compared with those without hepatotoxicity [P = 0.001, odds ratio (OR) = 3.535].By contrast, the frequency of a wild-type (major) haplotype, "NAT2*4 ", was significantly lower in TB patients with hepatotoxicity than those without hepatotoxicity (P < 0.001, OR = 0.265).There was no association between NAT2 -haplotypes and skin rash or eosinophilia. CONCLUSION:The present study shows that NAT2 is one of the determinants of anti-TB drug-induced hepatotoxicity.Moreover, the haplotypes, NAT2*4 and NAT2*6A , are useful new biomarkers for predicting anti-TB drug-induced hepatotoxicity.
No takes yet. Share an insight, caveat, or question.
Norihide Higuchi (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: